Clinical Trial 52967

Berlin, NJ 08009


A Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Investigate the Effect of Tirzepatide on the Reduction of Morbidity and Mortality in Adults With Obesity

  • Be at least 40 years of age
  • Have a BMI of 27kg/m2 or higher
  • Have either established cardiovascular disease or cardiovascular risk factors
  • NOT have type 1 or type 2 diabetes
  • Additional criteria apply

Qualified Participants May Receive:

  • Study-related care at no cost
  • Compensation up to $1,484 for time and trial-related travel expenses

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.